- Open Access
Gene trapping identifies transiently induced survival genes during programmed cell death
© Wempe et al., licensee BioMed Central Ltd 2001
- Received: 5 February 2001
- Accepted: 16 May 2001
- Published: 27 June 2001
The existence of a constitutively expressed machinery for death in individual cells has led to the notion that survival factors repress this machinery and, if such factors are unavailable, cells die by default. In many cells, however, mRNA and protein synthesis inhibitors induce apoptosis, suggesting that in some cases transcriptional activity might actually impede cell death. To identify transcriptional mechanisms that interfere with cell death and survival, we combined gene trap mutagenesis with site-specific recombination (Cre/loxP system) to isolate genes from cells undergoing apoptosis by growth factor deprivation.
From an integration library consisting of approximately 2 × 106 unique proviral integrations obtained by infecting the interleukin-3 (IL-3)-dependent hematopoietic cell line - FLOXIL3 - with U3Cre gene trap virus, we have isolated 125 individual clones that converted to factor independence upon IL-3 withdrawal. Of 102 cellular sequences adjacent to U3Cre integration sites, 17% belonged to known genes, 11% matched single expressed sequence tags (ESTs) or full cDNAs with unknown function and 72% had no match within the public databases. Most of the known genes recovered in this analysis encoded proteins with survival functions.
We have shown that hematopoietic cells undergoing apoptosis after withdrawal of IL-3 activate survival genes that impede cell death. This results in reduced apoptosis and improved survival of cells treated with a transient apoptotic stimulus. Thus, apoptosis in hematopoietic cells is the end result of a conflict between death and survival signals, rather than a simple death by default.
- Gene Trap
- alkB Gene
- Gene Trapping
- Growth Factor Withdrawal
- FDCP1 Cell
The idea of a constitutively expressed death machinery in each cell has given way to the notion that survival factors repress this machinery and, if such factors are unavailable, cells default into death [1,2,3]. This theory is supported by findings showing that many forms of programmed cell death do not require mRNA or protein synthesis. In fact, mRNA and protein synthesis inhibitors can induce apoptosis, suggesting that in some cases transcriptional activity might actually impede cell death [4,5].
To identify genes that are transcriptionally regulated in cells undergoing apoptosis by survival factor deprivation, we used a gene trap approach. Gene trapping involves introduction of a reporter gene into a random collection of chromosomal sites, including transcriptionally active regions. By selecting for gene expression, recombinants are obtained in which the reporter gene is fused to the regulatory elements of an endogenous gene. Transcripts generated by these fusions faithfully reflect the activity of a disrupted cellular gene and serve as a molecular tag to clone any gene linked to a specific function [6,7].
To identify genes that are transiently expressed during a biological process, we developed a strategy, which makes use of the site-specific recombination system Cre/loxP. By combining gene trap mutagenesis with site-specific recombination, it is possible to uncouple a trapped cellular promoter from a transduced reporter gene. This enables the recovery of recombinants even in the absence of an active cellular promoter and thus allows selection for integrations into transiently expressed genes [8,9].
Analysis of several recombinants obtained by this method indicated that cells upregulate survival genes before committing to cell death. As a result, cells receiving a transient apoptotic stimulus exhibit improved survival in a growth factor deficient environment.
A majority of gene trap sequence tags recovered following IL-3 withdrawal correspond to unknown genes
Most genes induced by IL-3 withdrawal exhibit cell-protective functions
Summary of previously characterized genes disrupted by gene trap mutagenesis
Type of protein
GEF for Rho-family GTPases
DH-domain containing oncogene
GEF for Rho-family GTPases
DH-domain containing oncogene
PIP5K type Iβ
PIP5K type Iγ /Tjp3
Cell cycle regulated protein associated with proliferation
Represses Fas transcription, activates MDR1 transcription
Inhibits Fas/FasL signal transduction
Vesicular monoamine transporter
Sequesters neuro-toxins in synaptic vesicles
Protects DNA against alkylation
DNA double-strand break repair
DNA double-strand break repair
Mediates intercellular adhesion
Nitrogen metabolism, tumor suppression
Another gene with a putative survival function encodes the cell-cycle-regulated protein p38-2G4 (EBP1). Although less well characterized than the above proteins, P38-G4 is absent from Go cells and may stimulate cell-cycle progression [23,24].
Another class of survival genes inhibits apoptosis by interfering with Fas signaling. It includes the IL-12 receptor, which inhibits Fas-mediated apoptosis in certain types of T lymphocytes  and the transcription factor YB-1, which represses Fas gene expression . Interestingly, YB-1 also activates the expression of the multidrug resistance gene (MDR1) whose product, the P glycoprotein, is an efflux pump that eliminates a variety of toxins from the cell, including proapoptotic anticancer drugs .
Similarly cytoprotective is VMAT2, the protein product of the vesicular monoamine transporter gene, which moves cytoplasmic monoamine transmitters into secretory vesicles and prevents cell death by sequestering proapoptotic molecules such as MPP+ and histamine [28,29].
Finally, IL-3 withdrawal induced transcription of several DNA repair genes. These were the mouse homologs of the bacterial alkB gene and of the yeast rec8 and rad50 genes. While AlkB protects DNA from damage by alkylating agents , Rec8 and Rad50 are DNA double-strand break repair proteins [31,32,33]. DNA double-strand breaks typically develop at the conclusion of any apoptotic process.
Only a few genes upregulated by IL-3 withdrawal (4 out of 15) were not directly related to cell death or survival and their induction may reflect some secondary events occurring during apoptosis (Table 1). However, the low frequency with which such genes were recovered underscores the specificity of the gene trap approach.
Mouse cDNA expression arrays reveal differential expression of cell death and survival genes following IL-3 withdrawal
To further study transcriptional regulation during growth factor starvation, we analyzed the expression patterns of a large number of previously characterized genes in FDCP1 cells undergoing apoptosis by IL-3 withdrawal using Atlas mouse cDNA arrays (Clontech). Atlas arrays contain cDNA probes for 588 genes involved in development, oncogenesis, DNA repair, tumor suppression and apoptosis.
Similar to the trapping results, several genes with survival functions were upregulated in the absence of IL-3. Among these were the survival kinase Akt, the c-kit receptor tyrosine kinase, the potent inhibitor of apoptosis FlipL, and the IL-3-receptor itself [34,35,36].
Moreover, survival functions seemed to be strengthened by the transient downregulation of the proapoptotic activin receptor [37,38]. In confirmation of previous results, however, the expression of several survival genes appeared IL-3 dependent. Thus, transcripts for antiapoptotic Pim-1, c-Myc and Bcl-XL proteins were repressed in the absence of IL-3 . Finally, only two genes with arguably proapoptotic functions (that is, JunD and Chop10) were upregulated in these experiments (Figure 4c) .
Taken together, the gene trap and cDNA array results suggested that the transcriptional changes at the onset of apoptosis should favor cell survival rather than cell death.
Apoptotic prestimulation improves survival in the absence of IL-3
In a second approach, we directly tested whether cells pre-exposed to factor deprivation develop increased apoptotic tolerance to subsequent factor starvation. To this end, IL-3 was initially withdrawn from FDCP1 cells for 1 or 2 hours. Subsequently, IL-3 was re-added for 4 hours only to be removed again for 6, 9 and 12 hours. At these time points cells were stained with annexin and apoptosis was quantified by flow cytometry. Figure 5b shows that pretreated cells died significantly more slowly that their non-pretreated counterparts, indicating that apoptotic prestimulation increases resistance to factor deprivation. Like the clonal survival assays, the cell protective effect was highest after a prestimulation of 2 hours.
On the basis of these results, we conclude that cell protective mechanisms are activated following growth factor withdrawal and transiently prevail prior to irreversible commitment to death.
A gene trap strategy was used to identify genes induced in hematopoietic cells undergoing apoptosis by growth factor withdrawal. This approach enables identification of transiently expressed genes that are difficult to isolate by standard methodology. A comparatively large proportion of unknown genes were recovered, which underscores the strategy's potential for isolating novel genes. In contrast to conventional gene trapping, which tags and disrupts random genes , the Cre/loxP approach allows enrichment for genes induced by specific biological stimuli. As most regulatory genes are expressed in a temporally and spatially restricted manner, we believe that the combination of gene trap mutagenesis and site-specific recombination provides a sound alternative for functional gene analysis in the post-genomic era. As judged by the small fraction of recombinants recovered after growth factor deprivation (that is, 124 of 2 × 106 or 0.006%)  and by the identity of the trapped known genes, the strategy seems highly specific for regulatory genes induced during programmed cell death. Accordingly, the majority of genes upregulated by IL-3 withdrawal were associated with cell death and survival. Although this was similar on the cDNA arrays, the differentially expressed genes recovered with the two methods were quite different. Thus, with the exception of YB1 and rad50, none of the genes displayed on the arrays were tagged by gene trap mutagenesis. Moreover, YB1 and rad50, despite being recovered in the gene trap approach as induced by IL-3 withdrawal, appeared constitutively expressed or even downregulated on both arrays and northern blots, respectively (Figures 3,4). Several factors may explain this difference. First, the integration library used here covered only 25% of the genome. As only seven genes were induced on the arrays (those encoding Akt, IL-3 receptor, glutathione-S-transferase, FlipL, c-kit, JunD and Chop10) their recovery from an unsaturated library was unlikely. Second, transient gene trapping as opposed to cDNA hybridization has no bias towards highly expressed genes. Third, the gene trap strategy selects for real gene inductions and, unlike the arrays and northern blots, is independent of pre-existing steady-state mRNA levels subjected to post-transcriptional regulation. Taken together, these considerations suggest that for the functional analysis of the mammalian genome, gene trapping effectively complements cDNA-based strategies, including cDNA arrays, which are unable to distinguish between transcriptional and/or post-transcriptional changes in gene expression.
In terms of apoptosis, FDCP1 cells apparently possess additional control mechanisms that operate at transcriptional level. Whereas in most cells conflicts between prosurvival and apoptotic signals are carried out post-translationally by well characterized proteins (for example, Bcl-2 family members, caspases), there is increasing evidence for transcriptional regulators of apoptosis capable of tilting the balance between the constitutively expressed pro- and anti-apoptotic proteins [20,41]. These transcriptional regulators of apoptosis - still largely unknown - are likely to confer tissue specificity on the apoptotic process. The identity of such regulators is of considerable interest as they could provide valuable targets for prospective anti-neoplastic and/or anti-degenerative drugs.
Most genes identified in this study encode cell protective and/or pro-survival functions. In line with this, the biological experiments described here have shown such functions to materialize in cells exposed to apoptotic prestimulation. Accordingly, cells receiving stimulation exhibited improved survival and reduced apoptosis in a growth factor deprived environment. Interestingly, a similar cytoprotective phenomenon known as ischemic preconditioning has been observed in animal models. In this, a short, sublethal period of ischemia induces profound resistance to subsequent ischemic events . Thus, induction of anti-apoptotic gene expression prior to a lethal stimulus seems to raise the threshold required for that stimulus to be effective. This provides an additional safety mechanism that can prevent unwanted loss of cells exposed only accidentally to apoptotic stimulation.
In summary, the present experiments have shown that hematopoietic cells undergoing apoptosis by IL-3 withdrawal activate survival genes that do impede cell death. This suggests that apoptosis in hematopoietic cells is the end result of a conflict between death and survival signals, rather than a simple death by default.
Amplification and cloning of upstream sequences
Inverse PCR from genomic DNAs was performed using the Cre-specific primers described previously  and a combination of the blunt end restriction enzymes SspI and HincII. 5'RACE was performed with 1 μg of total RNA using the 5'RACE kit from Gibco-BRL and the manufacturer's instructions. The specific Cre reverse primers were as follows:5'-TGCGAACCTCATCACTCGTTG-3',5'-CATGTCCATCAGGTTCTTGCG-3' (nested). Amplification reactions were performed in a Perkin Elmer thermocycler and cloned into the p-GEMT-vector (Promega) as described previously . Inserts were sequenced using an ABI 310 Genetic Analyzer (Perkin-Elmer).
Cell cultures and apoptosis assays
FDCP1 cells were propagated at concentrations of 2 × 105 cells/ml in Dulbecco's modified Eagle's medium (DMEM; Gibco), supplemented with 10% (v/v) fetal bovine serum (Boehringer-Mannheim) and 5 ng/ml recombinant mouse IL-3 (Peprotech) unless indicated otherwise. Agar cultures were an equal volume mixture of double-strength DMEM supplemented with 40% (v/v) fetal bovine serum and 0.6% (w/v) Bacto-agar (Difco) in double distilled water as previously described .
Apoptosis was measured in a FACScan flow cytometer after staining the cells with annexin using the Annexin-V-FLUOS detection kit (Roche) and the manufacturer's instructions.
Mouse cDNA expression arrays and northern blot hybridizations
Poly(A)+ RNA samples from FDCP-1 cells were reverse transcribed in the presence of 32P-labeled dATP and hybridized to Atlas Mouse cDNA Expression Array (Clontech) according to the manufacturer's instructions. Filters were scanned with a PhosphoImager (Molecular Dynamics) and analyzed with the AtlasImageTM 1.5 software (Clontech). For northern blots, 2.5 μg of poly(A)+ was fractionated in 1% formaldehyde-agarose gels, transferred onto Hybond N membranes (Amersham) and hybridized to specific 32P-dCTP-labeled probes produced by random priming (Rediprime, Amersham). Blots were exposed to Kodak-Biomax autoradiography film.
Cellular sequences adjacent to proviral integrations (gene trap sequence tags; GTSTs) were searched in the NCBI/NIH genomic databases  using the BlastN algorithm.
This work was supported in part by grants from Deutsche Krebshilfe and the Deutsche Forschungsgemeinschaft, Bonn to H.v.M and by Schering AG, Berlin.
- Jacobson M, Weil M, Raff M: Programmed cell death in animal development. Cell. 1997, 88: 347-354.View ArticleGoogle Scholar
- Raff MC: Social controls on cell survival and cell death. Nature. 1992, 356: 397-400.View ArticleGoogle Scholar
- Evan G, Littlewood T: A matter of life and cell death. Science. 1998, 281: 1317-1322. 10.1126/science.281.5381.1317.View ArticleGoogle Scholar
- Chinnaiyan A, Dixit V: The cell-death machine. Curr Biol. 1996, 6: 555-562.View ArticleGoogle Scholar
- White E: Life, death, and the pursuit of apoptosis. Genes Dev. 1996, 10: 1-15.View ArticleGoogle Scholar
- Zambrowicz B, Friedrich G, Buxton E, Lilleberg S, Person C, Sands A: Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells. Nature. 1998, 392: 608-611.View ArticleGoogle Scholar
- Wiles MV, Vauti F, Otte J, Fuchtbauer EM, Ruiz P, Fuchtbauer A, Arnold HH, Lehrach H, Metz T, von Melchner H, Wurst W: Establishment of a gene-trap sequence tag library to generate mutant mice from embryonic stem cells. Nat Genet. 2000, 24: 13-14. 10.1038/71622.View ArticleGoogle Scholar
- Thorey IS, Muth K, Russ AP, Otte J, Reffelmann A, von Melchner H: Selective disruption of genes transiently induced during early mouse development using gene trap mutagenesis and site specific recombination. Mol Cell Biol. 1998, 18: 3081-3088.View ArticleGoogle Scholar
- Russ AP, Friedel C, Ballas K, Kalina U, Zahn D, Strebhardt K, von Melchner H: Identification of genes induced by factor deprivation in hematopoietic cells undergoing apoptosis using gene-trap mutagenesis and site-specific recombination. Proc Natl Acad Sci USA. 1996, 93: 15279-15284.View ArticleGoogle Scholar
- Chan A, Takai S, Yamada K, Miki T: Isolation of a novel oncogene, NET1, from neuroepithelioma cells by expression cDNA cloning. Oncogene. 1996, 12: 1259-1266.Google Scholar
- Reid T, Bathoorn A, Ahmadian MR, Collard JG: Identification and characterization of hPEM-2, a guanine nucleotide exchange factor specific for Cdc42. J Biol Chem. 1999, 274: 33587-33593.View ArticleGoogle Scholar
- Zohn IM, Campbell SL, Khosravi-Far R, Rossman KL, Der CJ: Rho family proteins and Ras transformation: the RHOad less traveled gets congested. Oncogene. 1998, 17: 1415-1438. 10.1038/sj/onc/1202181.View ArticleGoogle Scholar
- Zhu K, Debreceni B, Li R, Zheng Y: Identification of Rho GTPase-dependent sites in the Dbl homology domain of oncogenic Dbl that are required for transformation. J Biol Chem. 2000, 275: 25993-26001.View ArticleGoogle Scholar
- Cerione RA, Zheng Y: The Dbl family of oncogenes. Curr Opin Cell Biol. 1996, 8: 216-222.View ArticleGoogle Scholar
- Guthridge MA, Stomski FC, Barry EF, Winnall W, Woodcock JM, McClure BJ, Dottore M, Berndt MC, Lopez AF: Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival. Mol Cell. 2000, 6: 99-108.View ArticleGoogle Scholar
- Mejillano M, Yamamoto M, Rozelle AL, Sun HQ, Wang X, Yin HL: Regulation of apoptosis by phosphatidylinositol 4,5-bisphosphate inhibition of caspases, and caspase inactivation of phosphatidylinositol phosphate 5-kinases. J Biol Chem. 2001, 276: 1865-1872.View ArticleGoogle Scholar
- del Peso L, González-Garcia M, Page C, Herrera R, Nunez G: Interleukin-3-induced phosphorylation of BAD through the protein kinase akt. Science. 1997, 278: 687-689.View ArticleGoogle Scholar
- Songyang Z, Baltimore D, Cantley L, Kaplan D, Franke T: Interleukin 3-dependent survival by the Akt protein kinase. Proc Natl Acad Sci USA. 1997, 94: 11345-11350.View ArticleGoogle Scholar
- Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC: Regulation of cell death protease caspase-9 by phosphorylation. Science. 1998, 282: 1318-1321. 10.1126/science.282.5392.1318.View ArticleGoogle Scholar
- Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999, 96: 857-868.View ArticleGoogle Scholar
- Baukrowitz T, Schulte U, Oliver D, Herlitze S, Krauter T, Tucker S, Ruppersberg J, Fakler B: PIP2 and PIP as determinants for ATP inhibition of KATP channels. Science. 1998, 282: 1141-1144. 10.1126/science.282.5391.1141.View ArticleGoogle Scholar
- Yu SP, Yeh CH, Sensi SL, Gwag BJ, Canzoniero LMT, Farhangrazi ZS, Ying HS, Tian M, Dugan LL, Choi DW: Mediation of neuronal apoptosis by enhancement of outward potassium current. Science. 1997, 278: 114-117.View ArticleGoogle Scholar
- Radomski N, Jost E: Molecular cloning of a murine cDNA encoding a novel protein, p38-2G4, which varies with the cell cycle. Exp Cell Res. 1995, 220: 434-445. 10.1006/excr.1995.1335.View ArticleGoogle Scholar
- Lamartine J, Seri M, Cinti R, Heitzmann F, Creaven M, Radomski N, Jost E, Lenoir GM, Romeo G, Sylla BS: Molecular cloning and mapping of a human cDNA (PA2G4) that encodes a protein highly homologous to the mouse cell cycle protein p38-2G4. Cytogenet Cell Genet. 1997, 78: 31-35.View ArticleGoogle Scholar
- Estaquier J, Idziorek T, Zou W, Emilie D, Farber CM, Bourez JM, Ameisen JC: T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J Exp Med. 1995, 182: 1759-1767.View ArticleGoogle Scholar
- Lasham A, Lindridge E, Rudert F, Onrust R, Watson J: Regulation of the human fas promoter by YB-1, Puralpha and AP-1 transcription factors. Gene. 2000, 252: 1-13. 10.1016/S0378-1119(00)00220-1.View ArticleGoogle Scholar
- Ohga T, Uchiumi T, Makino Y, Koike K, Wada M, Kuwano M, Kohno K: Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J Biol Chem. 1998, 273: 5997-6000.View ArticleGoogle Scholar
- Liu Y, Peter D, Roghani A, Schuldinger S, Prive GG, Eisenberg D, Brecha N, Edwards RH: A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell. 1992, 70: 539-551.View ArticleGoogle Scholar
- Prinz C, Zanner R, Gerhard M, Mahr S, Neumayer N, Hohne-Zell B, Gratzl M: The mechanism of histamine secretion from gastric enterochromaffin-like cells. Am J Physiol. 1999, 277: C845-C855.Google Scholar
- Wei YF, Carter KC, Wang RP, Shell BK: Molecular cloning and functional analysis of a human cDNA encoding an Escherichia coli AlkB homolog, a protein involved in DNA alkylation damage repair. Nucleic Acids Res. 1996, 24: 931-937.View ArticleGoogle Scholar
- Parisi S, McKay MJ, Molnar M, Thompson MA, van der Spek PJ, van Drunen-Schoenmaker E, Kanaar R, Lehmann E, Hoeijmakers JH, Kohli J: Rec8p, a meiotic recombination and sister chromatid cohesion phosphoprotein of the Rad21p family conserved from fission yeast to humans. Mol Cell Biol. 1999, 19: 3515-3528.View ArticleGoogle Scholar
- Dasika GK, Lin SC, Zhao S, Sung P, Tomkinson A, Lee EY: DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene. 1999, 18: 7883-7899. 10.1038/sj/onc/1203283.View ArticleGoogle Scholar
- Luo G, Yao MS, Bender CF, Mills M, Bladl AR, Bradley A, Petrini JH: Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation. Proc Natl Acad Sci USA. 1999, 96: 7376-7381.View ArticleGoogle Scholar
- Datta SR, Brunet A, Greenberg ME: Cellular survival: a play in three Akts. Genes Dev. 1999, 13: 2905-2927.View ArticleGoogle Scholar
- Migliaccio G, Migliaccio AR, Valinsky J, Langley K, Zsebo K, Visser JW, Adamson JW: Stem cell factor induces proliferation and differentiation of highly enriched murine hematopoietic cells. Proc Natl Acad Sci USA. 1991, 88: 7420-7424.View ArticleGoogle Scholar
- Tschopp J, Irmler M, Thome M: Inhibition of fas death signals by FLIPs. Curr Opin Immunol. 1998, 10: 552-558.View ArticleGoogle Scholar
- Friedman AD: GADD153/CHOP, a DNA damage-inducible protein, reduced CAAT/enhancer binding protein activities and increased apoptosis in 32D c13 myeloid cells. Cancer Res. 1996, 56: 3250-3256.Google Scholar
- Ying SY, Zhang Z, Furst B, Batres Y, Huang G, Li G: Activins and activin receptors in cell growth. Proc Soc Exp Biol Med. 1997, 214: 114-122.View ArticleGoogle Scholar
- Johnson DE: Regulation of survival pathways by IL-3 and induction of apoptosis following IL-3 withdrawal. Front Biosci. 1998, 3: d313-d324.Google Scholar
- Zhou F, Thompson EB: Role of c-jun induction in the glucocorticoid-evoked apoptotic pathway in human leukemic lymphoblasts. Mol Endocrinol. 1996, 10: 306-316.Google Scholar
- Barkett M, Gilmore TD: Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene. 1999, 18: 6910-6924. 10.1038/sj/onc/1203238.View ArticleGoogle Scholar
- Ishida T, Yarimizu K, Gute DC, Korthuis RJ: Mechanisms of ischemic preconditioning. Shock. 1997, 8: 86-94.View ArticleGoogle Scholar
- NCBI/NIH genomic databases. [http://www.ncbi.nlm.nih.gov]